YAPping about differentiation therapy in muscle cancer

MatthewN Svalina, Charles Keller

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Overcoming a presumed differentiation block in the childhood muscle cancer embryonal rhabdomyosarcoma is often thought to hold promise as an approach to replace cytotoxic chemotherapy with molecularly-targeted differentiation therapies. In this issue of Cancer Cell, Tremblay and colleagues implicate YAP1 and the Hippo signaling pathway in the maintenance of differentiation-arrested and proliferative phenotypes for embryonal rhabdomyosarcoma.

Original languageEnglish (US)
Pages (from-to)154-155
Number of pages2
JournalCancer Cell
Volume26
Issue number2
DOIs
Publication statusPublished - Aug 11 2014

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this